An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers

Author:

Stollings Joanna L.12ORCID,Poyant Janelle O.3ORCID,Groth Christine M.4ORCID,Rappaport Stephen H.4,Kruer Rachel M.5,Miller Emily5,Whitten Jessica A.6,Mcintire Allyson M.6,McDaniel Cara M.7,Betthauser Kevin D.8,Mohammad Rima A.9,Kenes Michael T.9,Korona Rebecca Bookstavar10,Barber Alexandra E.10ORCID,MacTavish Pamela11,Dixit Deepali12,Yeung Siu Yan A.13

Affiliation:

1. Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA

2. Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Nashville, TN, USA

3. Department of Pharmacy, Tufts Medical Center, Boston, MA, USA

4. Department of Pharmacy, University of Rochester Medical Center, Rochester, NY, USA

5. Department of Pharmacy, Indiana University Health, Adult Academic Health Center, Indianapolis, IN, USA

6. Department of Pharmacy, Eskenazi Health, Indianapolis, IN, USA

7. Department of Pharmacy, Thomas Jefferson University Hospital, Philadelphia, PA, USA

8. Department of Pharmacy Services, Barnes-Jewish Hospital, St. Louis, MO, USA

9. Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA

10. Department of Pharmacy, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA

11. Pharmacy Department, Glasgow Royal Infirmary, Glasgow, Scotland

12. Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, USA

13. Department of Pharmacy Services, University of Maryland Medical Center, Baltimore, MD, USA

Abstract

Background Post-intensive care syndrome (PICS) is defined as a new or worsening impairment in physical, cognitive, or mental health following critical illness. Intensive care unit recovery centers (ICU-RC) are one means to treat patients who have PICS. The purpose of this study is to describe the role of pharmacists in ICU-RCs. Research Question What is the number and type of medication interventions made by a pharmacist at an ICU-RC at 12 different centers? Study Design and Methods This prospective, observational study was conducted in 12 intensive care units (ICUs)/ICU-RCs between September 2019 and July 2021. A full medication review was conducted by a pharmacist on patients seen at the ICU-RC. Results 507 patients were referred to the ICU-RC. Of these patients, 474 attended the ICU-RC and 472 had a full medication review performed by a pharmacist. Baseline demographic and hospital course data were obtained from the electronic health record and at the ICU-RC appointment. Pharmacy interventions were made in 397 (84%) patients. The median number of pharmacy interventions per patient was 2 (interquartile range [IQR] = 1,3). Medications were stopped and started in 124 (26%) and 91 (19%) patients, respectively. The number of patients that had a dose decreased and a dose increased was 51 (11%) and 43 (9%), respectively. There was no difference in the median total number of medications that the patient was prescribed at the start and end of the patient visit (10, IQR = 5, 15). Adverse drug event (ADE) preventive measures were implemented in 115 (24%) patients. ADE events were identified in 69 (15%) patients. Medication interactions were identified in 30 (6%) patients. Interpretation A pharmacist plays an integral role in an ICU-RC resulting in the identification, prevention, and treatment of medication-related problems. This paper should serve as a call to action on the importance of the inclusion of a pharmacist in ICU-RC clinics.

Publisher

SAGE Publications

Subject

Critical Care and Intensive Care Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3